1	Tras	tras	SPS00	-	-	0-4	210(4)_ANS_clinical_caseMIR	SENT1	-	-
2	la	el	DA0FS0	-	-	5-7	210(4)_ANS_clinical_caseMIR	SENT1	-	-
3	resolución	resolución	NCFS000	-	-	8-18	210(4)_ANS_clinical_caseMIR	SENT1	-	-
4	del	del	SP+DA	-	-	19-22	210(4)_ANS_clinical_caseMIR	SENT1	-	-
5	cuadro	cuadro	NCMS000	-	-	23-29	210(4)_ANS_clinical_caseMIR	SENT1	-	-
6	agudo	agudo	AQ0MS0	C0205178	calificador	30-35	210(4)_ANS_clinical_caseMIR	SENT1	-	-
7	,	,	Fc	-	-	35-36	210(4)_ANS_clinical_caseMIR	SENT1	-	-
8	es	ser	VSIP3S0	-	-	37-39	210(4)_ANS_clinical_caseMIR	SENT1	-	-
9	frecuente	frecuente	AQ0CS0	C0332183	calificador	40-49	210(4)_ANS_clinical_caseMIR	SENT1	-	-
10	el	el	DA0MS0	-	-	50-52	210(4)_ANS_clinical_caseMIR	SENT1	-	-
11	desarrollo	desarrollo	NCMS000	-	-	53-63	210(4)_ANS_clinical_caseMIR	SENT1	-	-
12	de	de	SPS00	C0332285	atributo	64-66	210(4)_ANS_clinical_caseMIR	SENT1	-	-
13	panhipopituitarismo	panhipopituitarismo	NC00SC0	C0242343#C0242342	trastorno	67-86	210(4)_ANS_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
14	.	.	Fp	-	-	86-87	210(4)_ANS_clinical_caseMIR	SENT1	-	-

